This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Cardiovascular
Cardiovascular
Womens Health
Women's Health
two kidneys
Nephrology
Oncology
Oncology
Ophthalmology
Ophthalmology
Respiratory
Respiratory
Bayer for ProfessionalsYour Resource Portal

Latest resources
View more
Fitter resources
Step-by-step instructions to guide you through the preparation and fitting of IUS/IUD.
PP-PF-WHC-IUS-GB-0060, February 2024
Fitting Service Resources
Access useful, downloadable IUS and LARC resources for HCPs and patients.
PP-PF-WHC-IUS-GB-0109, August 2025
Retinal Pioneers Programme
A source of on-demand, educational resources developed in collaboration with national and international thought leaders
PP-EYL-GB-2908, August 2025
NUBEQA® (darolutamide) Resources
PP-NUB-GB-2048, February 2025
Events & webinars
View more
REGISTER HERE - CV Summit
3rd - 4th October 2025 | London
PP-BEY-GB-0009, July 2025
Resources to support prostate cancer patients
A focus on drug-to-drug interactions, managing risk and navigating around psychosexual health.
PP-NUB-GB-2385, June 2025
Exploring the mHSPC Patient Journey
Join experts for evidence-based treatment strategies on the application of triple therapy in mHSPC.
PP-NUB-GB-2382, June 2025
Finding consensus on utilising triplet therapy in mHSPC p...
Discussing triplet therapy in low-burden metastatic hormone-sensitive prostate cancer (mHSPC).
PP-NUB-GB-2383, June 2025
Learning Zone
View more
Request An Interactive Pharmacist’s Guide
NUBEQA® (darolutamide)
PP-NUB-GB-2388, May 2025
NUBEQA® (darolutamide) Drug-Drug Interactions Learning Guide
PP-NUB-GB-2129, March 2025
Urogenital Symptoms and Sexual Difficulties
(5 mins) Often underreported and undertreated symptoms that significantly affect a woman's relationships.
PP-PF-WHC-IUS-GB-0085 October 2024
Musculoskeletal Symptoms, Anxiety, Low Mood and Brain Fog
(4 mins) Causes for musculoskeletal (MSK) symptoms, how menopause can worsen existing anxiety and depression.
PP-PF-WHC-IUS-GB-0084 October 2024
Podcasts
View more
Bonus Episode
with All Speakers
PP-EYL-GB-2553, December 2024
Drying Effects of EYLEA® (aflibercept) 8 mg
with Hani Hasan, Rossella Anzidei and Richard Gale
PP-EYL-GB-2552, December 2024
The Importance of Clinical Audits
with Hani Hasan
PP-EYL-GB-2551, December 2024
Practicalities of Using EYLEA® (aflibercept) 8 mg in Rout...
with Bhavin Maru
PP-EYL-GB-2550, January 2025
Products
View more
Beyonttra®▼ (acoramidis) - Overview
About Beyonttra
PP-BEY-GB-0001, May 2025
NUBEQA® (darolutamide)
In nmCRPC and mHSPC
PP-NUB-GB-2217, March 2025
EYLEA® (aflibercept) 2 mg
Discover data and resources about EYLEA 2 mg
PP-EYL-GB-2793, March 2025
EYLEA® (aflibercept) 8 mg
Discover data and resources about EYLEA 8 mg
PP-EYL-GB-2911, July 2025
Register with BayerPRO

To access additional resources, personalise your experience and keep up to date via electronic communications from Bayer.